Related Experiment Video
Updated: Dec 18, 2025
Author Spotlight: Streamlining Visual Dynamics to Simplify Molecular Dynamics Simulations Using Gromacs
Published on: August 9, 2024
MDM2, an introduction
Tomoo Iwakuma1, Guillermina Lozano
1Section of Cancer Genetics, Department of Molecular Genetics, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Abstract:
The murine double minute 2 (mdm2) gene encodes a negative regulator of the p53 tumor suppressor. Amplification of mdm2 or increased expression by unknown mechanisms occurs in many tumors. Thus, increased levels of MDM2 would inactivate the apoptotic and cell cycle arrest functions of p53, as do deletion or mutation of p53, common events in the genesis of many kinds of tumors. MDM2 functions as an E3 ubiquitin ligase to degrade p53. MDM2 also binds another tumor suppressor, ARF. This interaction sequesters MDM2 in the nucleolus away from p53, thus activating p53. Many additional MDM2 interacting proteins have been identified. Functions of MDM2 independent of p53 have also been identified. This article is an introduction to MDM2, its structure and biological functions, as well as its relationship to its binding partners.
Insights
The murine double minute 2 (MDM2) protein regulates the p53 tumor suppressor. Increased MDM2 levels inactivate p53, promoting tumor growth, but MDM2 also interacts with other proteins like ARF.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- The murine double minute 2 (mdm2) gene is a key negative regulator of the p53 tumor suppressor.
- Amplification or overexpression of mdm2 is observed in numerous cancers, leading to p53 inactivation.
- p53 inactivation, via mdm2 or direct mutation/deletion, is a common event in tumor development.
Purpose of the Study:
- To introduce the structure and biological functions of MDM2.
- To explore the relationship between MDM2 and its binding partners, particularly p53 and ARF.
- To discuss MDM2 functions independent of p53.
Main Methods:
- Literature review and synthesis of existing research on MDM2.
- Analysis of MDM2's role as an E3 ubiquitin ligase.
- Examination of protein-protein interactions involving MDM2.
Main Results:
- MDM2 targets p53 for degradation via its E3 ubiquitin ligase activity.
- MDM2 binding to ARF sequesters MDM2 in the nucleolus, thereby activating p53.
- Numerous other MDM2-interacting proteins and p53-independent functions have been identified.
Conclusions:
- MDM2 plays a critical role in cancer development by regulating p53.
- Understanding MDM2's interactions and functions is crucial for cancer research.
- Further investigation into MDM2's diverse roles may reveal new therapeutic strategies.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
06:23Preparation of DMMTAV and DMDTAV Using DMAV for Environmental Applications: Synthesis, Purification, and Confirmation
Published on: March 9, 2018